L.A. jury awards $417 million in Johnson & Johnson talc powder case
Johnson & Johnson has sustained another major judicial loss in its defense of its talcum powder product.
On Aug. 22, the New York Times reported, “In what may be the largest award so far in a lawsuit tying ovarian cancer to talcum powder, a Los Angeles jury on Monday ordered Johnson & Johnson to pay $417 million in damages to a medical receptionist who developed ovarian cancer after using the company’s trademark Johnson’s Baby Powder on her perineum for decades.”
Eva Echeverria, 63, of East Los Angeles, was the plaintiff in the case, “one of thousands of women who have sued the consumer products giant Johnson & Johnson claiming baby powder caused their disease, pointing to studies linking talc to cancer that date to 1971, when scientists in Wales discovered particles of talc embedded in ovarian and cervical tumors.”
National Courts Monitor has charted the lawsuits across the United States against the company. In July, a jury in Missouri awarded $4.14 billion in punitive damages and $550 million in compensatory damages to women “who had accused the company of failing to warn them about cancer risks associated with its baby and body powders.”
The Aug. 20 award in California prompted a vow to appeal.
“A spokeswoman for Johnson & Johnson, Carol Goodrich, said the company would appeal the verdict handed up by a jury in the Superior Court of Los Angeles County and was preparing for additional trials,” according to the New York Times.